• Reidar Pedersen, Marianne Klungland Bahus, and Erik Martinsen Kvisle.
• Seksjon for medisinsk etikk, Universitetet i Oslo, Postboks 1130 Blindern, 0318 Oslo. reidar.pedersen@medisin.uio.no
• Tidsskr. Nor. Laegeforen. 2007 Jun 14;127(12):1648-50.

BackgroundIn the wake of medical progress an important ethical discussion has arisen about when to withhold and when to withdraw life-sustaining treatment.Material And MethodsLiterature on withholding and withdrawing life-sustaining treatment was assembled and analyzed, and common norms were compared with Norwegian legal regulations.ResultsWithholding or withdrawing life-sustaining treatment is not unusual when the treatment is regarded as futile. As opposed to euthanasia, limiting treatment is under certain circumstances legal. Core values--such as respect for the value of human life, the duty to save lives, equality, respect for patient autonomy, dignified death and professional integrity--may be given diverging emphases and interpretations. In many cases, the patient's capacity to consent is reduced, and it can be challenging to determine what is in the patient's best interest and when the treatment is futile. Good decision making processes and communication at the end of life is demanding, but may reduce and prevent many difficulties.InterpretationNorwegian healthcare legislation provides relatively little and to some extent unclear guidance on withholding and withdrawing life-sustaining treatment. National guidelines have not been developed. More attention could be paid to systematic approaches and dialogue with patients, relatives and all healthcare professionals about these issues.

29 keywords...

hide…